Mode of action and dose–response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study-Reference-Cited by-同舟云学术

Mode of action and dose–response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study

Published:2013-11-19 Issue:1 Volume:44 Page:83-119
ISSN:1040-8444
Container-title:Critical Reviews in Toxicology
language:en
Short-container-title:Critical Reviews in Toxicology

Author:

Budinsky R. A.,Schrenk D.,Simon T.,Van den Berg M.,Reichard J. F.,Silkworth J. B.,Aylward L. L.,Brix A.,Gasiewicz T.,Kaminski N.,Perdew G.,Starr T. B.,Walker N. J.,Rowlands J. C.

Publisher

Informa UK Limited

Subject

Toxicology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10408444.2013.835787

Reference404 articles.

1. Aryl Hydrocarbon Receptor Gene Silencing with Small Inhibitory RNA Differentially Modulates Ah-Responsiveness in MCF-7 and HepG2 Cancer Cells

2. An introduction to the molecular basics of aryl hydrocarbon receptor biology

3. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Insights into the measurement of hepatic cytochrome P450 1A2 induction*

4. Demystified ...: Apoptosis

5. Dioxin Increases the Interaction Between Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha at Human Promoters

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Species differences in specific ligand-binding affinity and activation of AHR: The biological basis for calculation of relative effective potencies and toxic equivalence factors;Regulatory Toxicology and Pharmacology;2024-05

2. Dose‐Response Assessment (Cancer and Non‐Cancer);Human and Ecological Risk Assessment;2024-04-05

3. Chemical-induced liver cancer: an adverse outcome pathway perspective;Expert Opinion on Drug Safety;2024-03-13

4. The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls;Regulatory Toxicology and Pharmacology;2024-01

5. A new paradigm for regulatory sciences;Regulatory Toxicology and Pharmacology;2023-12